Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1Lymphoid 1

Conditions

Breast Neoplasms 4Brain Neoplasms 4Prostatic Neoplasms 3Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Pinealoma 1Parotid Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Hypoxia 1Gynecologic Cancer 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Digestive System Diseases 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Brain Tumor Adult 1

Interventions

Temozolomide 163Radiosurgery 128Radiotherapy 106Bevacizumab 97Magnetic Resonance Spectroscopy 74Carboplatin 48Surgical Procedures, Operative 35Etoposide 34pembrolizumab 33Radiation 33Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Trastuzumab 25Lomustine 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Brain Neoplasms × gadobutrol × Clear all
NCT04132843 2022-11-21

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

M.D. Anderson Cancer Center

Phase NA Completed
6 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma

NCT02796729 2019-01-28

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

British Columbia Cancer Agency

Phase 2 Terminated
3 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Bayer

Phase 3 Completed
165 enrolled 24 charts
CNS

Brain Neoplasms

NCT02967380 2017-03-27

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

University of Southern California

Phase NA Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Multiple Sclerosis, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡